Table 1.
Patients' characteristics.
| Breast cancer patients | Group A | Group B | Group C |
|---|---|---|---|
| N = 41 | N = 17 | N = 7 | N = 17 |
| Age, years | 55.8 ± 13.5 | 55.7 ± 16.2 | 59.1 ± 13.2 |
| BMI, kg/m2 | 24.6 ± 4.7 | 25.4 ± 4.01 | 25.3 ± 5.4 |
| Dyslipidemia | 5 | 2 | 9 |
| Diabetes mellitus | 5 | 1 | 4 |
| Type of surgery | |||
| Mastectomy + AD | 12 | 7 | 14 |
| BCS + AD | 5 | 0 | 3 |
| Tumor size, cm | 2.1 ± 1.2 | 2.4 ± 1.6 | 1.9 ± 1.2 |
| Number of lymph nodes removed | 11.9 ± 6.9 | 13 ± 6.8 | 8.9 ± 4.9 |
| Number of metastatic lymph nodes | 3.2 ± 1.6 | 5.1 ± 7.2 | 2.1 ± 1.4 |
| Neoadjuvant chemotherapy | 4 | 1 | 9* |
| Hystological subtype | |||
| Ductal invasive carcinoma | 13 | 6 | 15 |
| Lobular invasive carcinoma | 3 | 1 | 2 |
| Metaplastic carcinoma | 1 | 0 | 0 |
| Immunoistochemical subtype | |||
| Luminal A | 5 | 4 | 7 |
| Luminal B | 9 | 1 | 5 |
| Triple negative | 2 | 1 | 3 |
| Her2 enriched | 1 | 1 | 2 |
Data are shown as mean ± SD and n.
AD, axillary dissection; BCS, breast conservative surgery.
*
P ≤ 0.05.